Magnetic cells for cancer therapy: Adopting magnets for cell-based cancer therapies

Gene Therapy

Volumn 15, Issue 23, 2008, Pages 1511-1512

  Kaluza, K ^a   Vile, R G ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNETIC NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; CANCER RESEARCH; CANCER STEM CELL; CELL FUNCTION; CELL THERAPY; ENDOTHELIUM CELL; HUMAN; IMMUNOGENICITY; MACROPHAGE; MAGNET; MAGNETIC FIELD; MALIGNANT NEOPLASTIC DISEASE; MONOCYTE; NONHUMAN; NOTE; PRIORITY JOURNAL; SPHEROID CELL; T LYMPHOCYTE;

ANIMALS; GENE THERAPY; HUMANS; MAGNETIC FIELD THERAPY; MONOCYTES; NEOPLASMS;

EID: 56349159511     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.139     Document Type: Note

References (9)

1. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006; 314: 126-129.
2. Thorne SH, Negrin RS, Contag CH. Synergistic antitumor effects of immune cell-viral biotherapy. Science 2006; 311: 1780-1784.
3. Griffiths L, Binley K, Iqball S, Kan O, Maxwell P, Ratcliffe P et al The macrophage - a novel system to deliver gene therapy to pathological hypoxia. Gene Therapy 2000; 7: 255-262.
4. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN et al. Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004; 96: 1593-1603.
5. Power AT, Wang J, Falls TJ, Paterson JM, Parato KA, Lichty BD et al Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity. Mol Ther 2007; 15: 123-130.
6. Muthana M, Scott SD, Farrow N, Morrow F, Murdoch C, Grubb S et al. A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Therapy 2008; 15: 902-910.
7. Hunder NN, Wallen H, Cao J, Hendricks DW, Reilly JZ, Rodmyre R et al Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med 2008; 358: 2698-2703.
8. Harrington KJ, Alvarez-Vallina L, Crittenden M, Gough M, Chong H, Diaz RM et al. Cells as vehicles for cancer gene therapy: The missing link between targeted vectors and systemic delivery. Hum Gene Ther 2002; 13: 1263-1280.
9. Qiao J, Kottke T, Willmon C, Galivo F, Wongthida P, Diaz RM et al. Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nat Med 2008; 14: 37-44.